Pain and Weight Treatment: Development and Trial of PAW
PAW
2 other identifiers
interventional
50
1 country
1
Brief Summary
Pediatric weight management efficacy is impacted by failure to complete treatment protocols and, for those that do complete treatment, a return to unhealthy behaviors. This project tests whether treating pain, a common comorbid condition to pediatric obesity, will enhance treatment. This study will generate results that can be translated into immediate improvements in care for families seeking treatment for pediatric obesity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 7, 2019
CompletedFirst Posted
Study publicly available on registry
August 6, 2019
CompletedStudy Start
First participant enrolled
August 14, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2026
CompletedJuly 14, 2025
June 1, 2025
6.7 years
June 7, 2019
July 9, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Mean difference in session attendance between groups
The number of sessions of fit5 attended will be compared between the group attending PAW and those in the information control group.
Through the 13 weeks that comprise fit5
Secondary Outcomes (15)
The feasibility and acceptability of the PAW intervention will be examined Via exit interviews
At the conclusion of the 13 weeks of the program
The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires.
At the conclusion of the 13 weeks of the program
The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires.
At the conclusion of the 13 weeks of the program
The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires.
At the conclusion of the 13 weeks of the program
The feasibility and acceptability of the PAW intervention will be examined via self-report psychosocial questionnaires.
At the conclusion of the 13 weeks of the program
- +10 more secondary outcomes
Study Arms (2)
PAW plus standard of care
ACTIVE COMPARATOREach PAW session will include handouts and worksheets to assist with new strategies as well as homework. Strategies taught within PAW will be integrated with the skills taught in weight management. For example, pain diaries will be kept along with food and exercise logs to examine relationships among pain, eating and activity.
Pain education plus standard of care
PLACEBO COMPARATORFor those randomized into the information-only group, sessions will be delivered in the same manner. Sessions will cover general pediatric pain management but no behavioral or cognitive skills training will be taught.
Interventions
Eligibility Criteria
You may qualify if:
- Males and females between 12 and 18 years of age
- Ability to speak, write and read English
- A parent or guardian who speaks, writes and reads English
- Signed consent and assent from the child and parent
- Enrollment in a weight management program
- Score greater than 3 on the Pain Burden Inventory at screening (in order to recruit adolescents who experience more than just general aches and pains).
- Youth reporting musculoskeletal pain
You may not qualify if:
- Parent or guardian unable to participate
- Patients on weight reducing medications
- Severe psychiatric illness (i.e., suicidal or hospitalization within past 6 months)
- Medical conditions such as Type 1 diabetes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Connecticut Children's Medical Center
Hartford, Connecticut, 06106, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Melissa Santos, PhD
Connecticut Children's Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 7, 2019
First Posted
August 6, 2019
Study Start
August 14, 2019
Primary Completion
May 1, 2026
Study Completion
May 1, 2026
Last Updated
July 14, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share
NA - we are not planning on sharing the data